Author:
Liem A K D,Cuijpers C E J,Zeilmaker M J
Reference127 articles.
1. Abraham K, Krowke R, Neubert D (1988). Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-response tissue distribution and induction of hepatic ethoxyresorufin-O-deethylase in rats following a single injection. Arch. Toxicol., 62:359–368.
2. Ahlborg U G, Becking G C, Birnbaum L S, Brouwer A, Derks H J G M, Feeley M, Golor G, Hanberg A, Larsen J C, Liem A K D, Safe S H, Schlatter C, Waern F, Younes M, Yrjanheikki E (1994). Toxic equivalency factors for dioxin-like PCBs. Report on a WHO-ECEH and IPCS consultation, December 1993. Chemosphere, 28: 1049–1067.
3. Alcock R E, Jones K C (1996). Dioxins in the environment: a review of trend data. Environ. Sci. Technol., 30: 3133–3143
4. Alder L, Beck H, Mathar W, Palavinskas R (1994). PCDDs, PCDFs, PCBs and other organochlorine compounds in human milk. Levels and their dynamics in Germany. Organohalogen Compds., 21: 39–44.
5. Andersen M E, Mills J J, Gargas M L, Kedderis L, Birnbaum L S, Neubert D, Greenlee W L (1993). Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. Risk analysis, 13: 25–36.